{"index":{"links":{"/.trash/HIV":[{"source":"/.trash/HIV","target":"/ART","text":"ART"}],"/notes/HPV+-OPSCC-incidence-over-time":[{"source":"/notes/HPV+-OPSCC-incidence-over-time","target":"/reference/vermorkenWhereWhenUse2021","text":"reference/@vermorkenWhereWhenUse2021"}],"/notes/archive/identity/professional-identity":[{"source":"/notes/archive/identity/professional-identity","target":"/finite_infinite_games_james_p_carse","text":"Carse's Finite and Infinite Games"}],"/notes/archive/learn/doing_science":[{"source":"/notes/archive/learn/doing_science","target":"/","text":"locally_saved_post"}],"/notes/chemo-emergencies":[{"source":"/notes/chemo-emergencies","target":"/taxane","text":"taxane"},{"source":"/notes/chemo-emergencies","target":"/rituximab","text":"rituximab"},{"source":"/notes/chemo-emergencies","target":"/daratumumab","text":"daratumumab"},{"source":"/notes/chemo-emergencies","target":"/obinutuzumab","text":"obinutuzumab"},{"source":"/notes/chemo-emergencies","target":"/gemtuzumab-ozogamicin","text":"gemtuzumab ozogamicin"},{"source":"/notes/chemo-emergencies","target":"/5-FU","text":"5-FU"},{"source":"/notes/chemo-emergencies","target":"/capecitabine","text":"capecitabine"},{"source":"/notes/chemo-emergencies","target":"/MTX","text":"MTX"},{"source":"/notes/chemo-emergencies","target":"/ifosfamide","text":"ifosfamide"},{"source":"/notes/chemo-emergencies","target":"/gemcitabine","text":"gemcitabine"},{"source":"/notes/chemo-emergencies","target":"/everolimus","text":"everolimus"},{"source":"/notes/chemo-emergencies","target":"/5-FU","text":"5-FU"},{"source":"/notes/chemo-emergencies","target":"/blinatumumab","text":"blinatumumab"}],"/notes/chemo-overview":[{"source":"/notes/chemo-overview","target":"/anthracyclines","text":"anthracyclines"},{"source":"/notes/chemo-overview","target":"/dirty-data","text":"dirty data"},{"source":"/notes/chemo-overview","target":"/adverse-effects","text":"adverse effects"},{"source":"/notes/chemo-overview","target":"/risk-mitigation","text":"risk mitigation"},{"source":"/notes/chemo-overview","target":"/anthracyclines","text":"anthracyclines"}],"/notes/commonplace_book":[{"source":"/notes/commonplace_book","target":"/Commonplace-Book","text":"Commonplace Book"},{"source":"/notes/commonplace_book","target":"/loci-communes","text":"loci communes"},{"source":"/notes/commonplace_book","target":"/florilegium","text":"florilegium"}],"/notes/design_of_everyday_things_don_norman":[{"source":"/notes/design_of_everyday_things_don_norman","target":"/Design-of-Everyday-Things","text":"Design of Everyday Things"},{"source":"/notes/design_of_everyday_things_don_norman","target":"/Don-Norman","text":"Don Norman"}],"/notes/hemepath-capstone-2022-07-12":[{"source":"/notes/hemepath-capstone-2022-07-12","target":"/data-science-opportunities","text":"data science opportunities"},{"source":"/notes/hemepath-capstone-2022-07-12","target":"/EHR-design","text":"EHR design"}],"/notes/mistakes":[{"source":"/notes/mistakes","target":"/Don-Norman","text":"Don Norman"},{"source":"/notes/mistakes","target":"/Atul-Gawande","text":"Atul Gawande"}],"/notes/oncology-alphabet-soup":[{"source":"/notes/oncology-alphabet-soup","target":"/CTCAE","text":"CTCAE"}],"/reference/vermorkenWhereWhenUse2021":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/HPV+-OPSCC-incidence-over-time","text":"HPV+ OPSCC incidence over time"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/OPSCC-HPV+-survival","text":"OPSCC HPV+ survival"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/HNSCC-timeline-of-therapies","text":"HNSCC timeline of therapies"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/MTX","text":"MTX"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/cisplatin","text":"cisplatin"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/bleomycin","text":"bleomycin"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/vinca_alkaloids","text":"vinca_alkaloids"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/5-FU","text":"5-FU"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/vincristine","text":"vincristine"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/CF_PF","text":"CF_PF"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/RTOG","text":"RTOG"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/intra-arterial","text":"intra-arterial"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/CCRT","text":"CCRT"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/taxanes","text":"taxanes"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/docetaxel","text":"docetaxel"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TPF","text":"TPF"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/ICT","text":"ICT"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TAX323_EORTC24971","text":"TAX323_EORTC24971"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TAX324","text":"TAX324"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/modified-TPF","text":"modified TPF"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/weekly-carbo+taxol","text":"weekly carbo+taxol"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TPEx","text":"TPEx"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/ICT-LA-HNSCC-indications","text":"ICT LA-HNSCC indications"}]},"backlinks":{"/":[{"source":"/notes/archive/learn/doing_science","target":"/","text":"locally_saved_post"}],"/5-FU":[{"source":"/notes/chemo-emergencies","target":"/5-FU","text":"5-FU"},{"source":"/notes/chemo-emergencies","target":"/5-FU","text":"5-FU"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/5-FU","text":"5-FU"}],"/ART":[{"source":"/.trash/HIV","target":"/ART","text":"ART"}],"/Atul-Gawande":[{"source":"/notes/mistakes","target":"/Atul-Gawande","text":"Atul Gawande"}],"/CCRT":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/CCRT","text":"CCRT"}],"/CF_PF":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/CF_PF","text":"CF_PF"}],"/CTCAE":[{"source":"/notes/oncology-alphabet-soup","target":"/CTCAE","text":"CTCAE"}],"/Commonplace-Book":[{"source":"/notes/commonplace_book","target":"/Commonplace-Book","text":"Commonplace Book"}],"/Design-of-Everyday-Things":[{"source":"/notes/design_of_everyday_things_don_norman","target":"/Design-of-Everyday-Things","text":"Design of Everyday Things"}],"/Don-Norman":[{"source":"/notes/design_of_everyday_things_don_norman","target":"/Don-Norman","text":"Don Norman"},{"source":"/notes/mistakes","target":"/Don-Norman","text":"Don Norman"}],"/EHR-design":[{"source":"/notes/hemepath-capstone-2022-07-12","target":"/EHR-design","text":"EHR design"}],"/HNSCC-timeline-of-therapies":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/HNSCC-timeline-of-therapies","text":"HNSCC timeline of therapies"}],"/HPV+-OPSCC-incidence-over-time":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/HPV+-OPSCC-incidence-over-time","text":"HPV+ OPSCC incidence over time"}],"/ICT":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/ICT","text":"ICT"}],"/ICT-LA-HNSCC-indications":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/ICT-LA-HNSCC-indications","text":"ICT LA-HNSCC indications"}],"/MTX":[{"source":"/notes/chemo-emergencies","target":"/MTX","text":"MTX"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/MTX","text":"MTX"}],"/OPSCC-HPV+-survival":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/OPSCC-HPV+-survival","text":"OPSCC HPV+ survival"}],"/RTOG":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/RTOG","text":"RTOG"}],"/TAX323_EORTC24971":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TAX323_EORTC24971","text":"TAX323_EORTC24971"}],"/TAX324":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TAX324","text":"TAX324"}],"/TPEx":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TPEx","text":"TPEx"}],"/TPF":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TPF","text":"TPF"}],"/adverse-effects":[{"source":"/notes/chemo-overview","target":"/adverse-effects","text":"adverse effects"}],"/anthracyclines":[{"source":"/notes/chemo-overview","target":"/anthracyclines","text":"anthracyclines"},{"source":"/notes/chemo-overview","target":"/anthracyclines","text":"anthracyclines"}],"/bleomycin":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/bleomycin","text":"bleomycin"}],"/blinatumumab":[{"source":"/notes/chemo-emergencies","target":"/blinatumumab","text":"blinatumumab"}],"/capecitabine":[{"source":"/notes/chemo-emergencies","target":"/capecitabine","text":"capecitabine"}],"/cisplatin":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/cisplatin","text":"cisplatin"}],"/daratumumab":[{"source":"/notes/chemo-emergencies","target":"/daratumumab","text":"daratumumab"}],"/data-science-opportunities":[{"source":"/notes/hemepath-capstone-2022-07-12","target":"/data-science-opportunities","text":"data science opportunities"}],"/dirty-data":[{"source":"/notes/chemo-overview","target":"/dirty-data","text":"dirty data"}],"/docetaxel":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/docetaxel","text":"docetaxel"}],"/everolimus":[{"source":"/notes/chemo-emergencies","target":"/everolimus","text":"everolimus"}],"/finite_infinite_games_james_p_carse":[{"source":"/notes/archive/identity/professional-identity","target":"/finite_infinite_games_james_p_carse","text":"Carse's Finite and Infinite Games"}],"/florilegium":[{"source":"/notes/commonplace_book","target":"/florilegium","text":"florilegium"}],"/gemcitabine":[{"source":"/notes/chemo-emergencies","target":"/gemcitabine","text":"gemcitabine"}],"/gemtuzumab-ozogamicin":[{"source":"/notes/chemo-emergencies","target":"/gemtuzumab-ozogamicin","text":"gemtuzumab ozogamicin"}],"/ifosfamide":[{"source":"/notes/chemo-emergencies","target":"/ifosfamide","text":"ifosfamide"}],"/intra-arterial":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/intra-arterial","text":"intra-arterial"}],"/loci-communes":[{"source":"/notes/commonplace_book","target":"/loci-communes","text":"loci communes"}],"/modified-TPF":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/modified-TPF","text":"modified TPF"}],"/obinutuzumab":[{"source":"/notes/chemo-emergencies","target":"/obinutuzumab","text":"obinutuzumab"}],"/reference/vermorkenWhereWhenUse2021":[{"source":"/notes/HPV+-OPSCC-incidence-over-time","target":"/reference/vermorkenWhereWhenUse2021","text":"reference/@vermorkenWhereWhenUse2021"}],"/risk-mitigation":[{"source":"/notes/chemo-overview","target":"/risk-mitigation","text":"risk mitigation"}],"/rituximab":[{"source":"/notes/chemo-emergencies","target":"/rituximab","text":"rituximab"}],"/taxane":[{"source":"/notes/chemo-emergencies","target":"/taxane","text":"taxane"}],"/taxanes":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/taxanes","text":"taxanes"}],"/vinca_alkaloids":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/vinca_alkaloids","text":"vinca_alkaloids"}],"/vincristine":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/vincristine","text":"vincristine"}],"/weekly-carbo+taxol":[{"source":"/reference/vermorkenWhereWhenUse2021","target":"/weekly-carbo+taxol","text":"weekly carbo+taxol"}]}},"links":[{"source":"/.trash/HIV","target":"/ART","text":"ART"},{"source":"/notes/HPV+-OPSCC-incidence-over-time","target":"/reference/vermorkenWhereWhenUse2021","text":"reference/@vermorkenWhereWhenUse2021"},{"source":"/notes/archive/identity/professional-identity","target":"/finite_infinite_games_james_p_carse","text":"Carse's Finite and Infinite Games"},{"source":"/notes/archive/learn/doing_science","target":"/","text":"locally_saved_post"},{"source":"/notes/chemo-emergencies","target":"/taxane","text":"taxane"},{"source":"/notes/chemo-emergencies","target":"/rituximab","text":"rituximab"},{"source":"/notes/chemo-emergencies","target":"/daratumumab","text":"daratumumab"},{"source":"/notes/chemo-emergencies","target":"/obinutuzumab","text":"obinutuzumab"},{"source":"/notes/chemo-emergencies","target":"/gemtuzumab-ozogamicin","text":"gemtuzumab ozogamicin"},{"source":"/notes/chemo-emergencies","target":"/5-FU","text":"5-FU"},{"source":"/notes/chemo-emergencies","target":"/capecitabine","text":"capecitabine"},{"source":"/notes/chemo-emergencies","target":"/MTX","text":"MTX"},{"source":"/notes/chemo-emergencies","target":"/ifosfamide","text":"ifosfamide"},{"source":"/notes/chemo-emergencies","target":"/gemcitabine","text":"gemcitabine"},{"source":"/notes/chemo-emergencies","target":"/everolimus","text":"everolimus"},{"source":"/notes/chemo-emergencies","target":"/5-FU","text":"5-FU"},{"source":"/notes/chemo-emergencies","target":"/blinatumumab","text":"blinatumumab"},{"source":"/notes/chemo-overview","target":"/anthracyclines","text":"anthracyclines"},{"source":"/notes/chemo-overview","target":"/dirty-data","text":"dirty data"},{"source":"/notes/chemo-overview","target":"/adverse-effects","text":"adverse effects"},{"source":"/notes/chemo-overview","target":"/risk-mitigation","text":"risk mitigation"},{"source":"/notes/chemo-overview","target":"/anthracyclines","text":"anthracyclines"},{"source":"/notes/commonplace_book","target":"/Commonplace-Book","text":"Commonplace Book"},{"source":"/notes/commonplace_book","target":"/loci-communes","text":"loci communes"},{"source":"/notes/commonplace_book","target":"/florilegium","text":"florilegium"},{"source":"/notes/design_of_everyday_things_don_norman","target":"/Design-of-Everyday-Things","text":"Design of Everyday Things"},{"source":"/notes/design_of_everyday_things_don_norman","target":"/Don-Norman","text":"Don Norman"},{"source":"/notes/hemepath-capstone-2022-07-12","target":"/data-science-opportunities","text":"data science opportunities"},{"source":"/notes/hemepath-capstone-2022-07-12","target":"/EHR-design","text":"EHR design"},{"source":"/notes/mistakes","target":"/Don-Norman","text":"Don Norman"},{"source":"/notes/mistakes","target":"/Atul-Gawande","text":"Atul Gawande"},{"source":"/notes/oncology-alphabet-soup","target":"/CTCAE","text":"CTCAE"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/HPV+-OPSCC-incidence-over-time","text":"HPV+ OPSCC incidence over time"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/OPSCC-HPV+-survival","text":"OPSCC HPV+ survival"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/HNSCC-timeline-of-therapies","text":"HNSCC timeline of therapies"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/MTX","text":"MTX"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/cisplatin","text":"cisplatin"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/bleomycin","text":"bleomycin"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/vinca_alkaloids","text":"vinca_alkaloids"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/5-FU","text":"5-FU"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/vincristine","text":"vincristine"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/CF_PF","text":"CF_PF"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/RTOG","text":"RTOG"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/intra-arterial","text":"intra-arterial"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/CCRT","text":"CCRT"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/taxanes","text":"taxanes"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/docetaxel","text":"docetaxel"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TPF","text":"TPF"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/ICT","text":"ICT"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TAX323_EORTC24971","text":"TAX323_EORTC24971"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TAX324","text":"TAX324"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/modified-TPF","text":"modified TPF"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/weekly-carbo+taxol","text":"weekly carbo+taxol"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/TPEx","text":"TPEx"},{"source":"/reference/vermorkenWhereWhenUse2021","target":"/ICT-LA-HNSCC-indications","text":"ICT LA-HNSCC indications"}]}